MTI Ltd. (TYO:9438)
789.00
-10.00 (-1.25%)
Apr 28, 2025, 3:30 PM JST
MTI Ltd. Revenue
MTI Ltd. had revenue of 7.27B JPY in the quarter ending December 31, 2024, with 9.76% growth. This brings the company's revenue in the last twelve months to 28.32B, up 7.53% year-over-year. In the fiscal year ending September 30, 2024, MTI Ltd. had annual revenue of 27.67B with 3.25% growth.
Revenue (ttm)
28.32B
Revenue Growth
+7.53%
P/S Ratio
1.54
Revenue / Employee
23.92M
Employees
1,184
Market Cap
43.66B
Revenue Chart
Revenue History
Fiscal Year End | Revenue | Change | Growth |
---|---|---|---|
Sep 30, 2024 | 27.67B | 871.00M | 3.25% |
Sep 30, 2023 | 26.80B | 319.00M | 1.20% |
Sep 30, 2022 | 26.48B | 736.00M | 2.86% |
Sep 30, 2021 | 25.74B | -339.00M | -1.30% |
Sep 30, 2020 | 26.08B | -1.03B | -3.80% |
Sep 30, 2019 | Pro | Pro | Pro |
Sep 30, 2018 | Pro | Pro | Pro |
Sep 30, 2017 | Pro | Pro | Pro |
Sep 30, 2016 | Pro | Pro | Pro |
Sep 30, 2015 | Pro | Pro | Pro |
Revenue Definition
Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. Revenue does not take any expenses into account and is therefore different from profits.
Full DefinitionRelated Stocks
Company Name | Revenue |
---|---|
Chugai Pharmaceutical | 1,222.12B |
Daiichi Sankyo Company | 1,795.99B |
Takeda Pharmaceutical Company | 4,579.02B |
HOYA Corporation | 838.60B |
Terumo | 1,011.15B |
Otsuka Holdings | 2,329.86B |
Astellas Pharma | 1,867.63B |
Olympus | 993.33B |